Task: Answer the MCQ question.
Query: Which drug exhibits a 4.865% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1c([N+](=O)[O-])c(C(=O)Sc2ccc(Br)cc2)nn1C
(b) O=C(CSc1nnc(-c2ccccc2Cl)o1)N1CCCCC1
(c) Nc1cc(N)nc(SCC(=O)N2CCCCC2)n1
Answer: c. Nc1cc(N)nc(SCC(=O)N2CCCCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1cc(N)nc(SCC(=O)N2CCCCC2)n1
Nc1cc(N)nc(SCC(=O)N2CCCCC2)n1
2-(4,6-diaminopyrimidin-2-yl)sulfanyl-1-piperidin-1-ylethanone